Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fimasartan and Atorvastatin in Essential Hypertension and Dyslipidemia (FIESTA)
NCT03338426Phase 3Completed
- Sponsor
- Boryung
- Start
- Jan 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fimasartan, atorvastatin in essential hypertension, dyslipidemia, sponsored by Boryung. Started Jan 2018; status: completed.
02
Drugs
fimasartanatorvastatin
03
Conditions
essential hypertensiondyslipidemia
Beyond the preview
Go deeper on NCT03338426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03338426.